Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-24 @ 3:35 PM
NCT ID:
NCT05665192
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with Primary myelofibrosis (PMF), post- Essential thrombocythemia (ET) Myelofibrosis (MF), or post- Polycythemia vera (PV) MF
* Treated with FEDR and initiated treatment after 16 August 2019.
* Received prior treatment with RUX.
* Had spleen assessed at time of initiation of FEDR by palpation.
* Able to read and speak English
* Willing to provide informed consent
* Willing to provide permission to the site to release her/his medical information to the study investigators according to the study-specific eCRF
* Willing to complete the baseline survey prior to first FEDR
Exclusion Criteria:
* Past or current participant in any FEDR-related clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05665192
Study Brief:
Protocol Section:
NCT05665192